Skip Navigation


Hum. Reprod. Advance Access originally published online on September 3, 2004
Human Reproduction 2004 19(12):2913-2918; doi:10.1093/humrep/deh514
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
19/12/2913    most recent
deh514v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Coticchio, G.
Right arrow Articles by Cecconi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coticchio, G.
Right arrow Articles by Cecconi, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction vol. 19 no. 12 © European Society of Human Reproduction and Embryology 2004; all rights reserved

Mouse oocyte meiotic resumption and polar body extrusion in vitro are differentially influenced by FSH, epidermal growth factor and meiosis-activating sterol

G. Coticchio1, G. Rossi2, A. Borini1, C. Grøndahl4, G. Macchiarelli3, C. Flamigni5, S. Fleming6 and S. Cecconi2,7

1 TECNOBIOS Procreazione, Bologna, 40125, 2 Department of Biomedical Sciences and Technologies, 3 Department of Experimental Medicine, University of L'Aquila, L'Aquila, 67010, Italy, 4 Novo Nordisk A/S, Copenhagen, 2820, Denmark, 5 University of Bologna, 40125, Bologna, Italy and 6 Department of Obstetrics & Gynaecology, University of Sydney, Sydney, NSW 2145, Australia

7 To whom correspondence should be addressed at: Department of Sciences and Biomedical Technologies, University of L'Aquila, Via Vetoio, Loc. Coppito, 67010 Coppito, L'Aquila, Italy. Email: cecconi{at}univaq.it

BACKGROUND: In this study, we compared the relative ability of FSH (100 mIU/ml), epidermal growth factor (EGF) (10 ng/ml), and follicular-fluid meiosis-activating sterol (FF-MAS, 10 µmol/l) to induce meiotic resumption and polar body I (PBI) extrusion in mouse oocytes. METHODS: Cumulus-enclosed oocytes (CEO) were co-incubated with meiosis-arresting agents, including 4 mmol/l hypoxanthine (Hx), 0.3 mmol/l dibutyryl cAMP (dbcAMP), and 8.5 µmol/l cilostamide, a selective inhibitor of the oocyte-specific phosphodiesterase 3 (PDE 3). RESULTS: In Hx-treated oocytes, FSH, EGF and FF-MAS induced meiosis resumption at very high rates, but only FSH and EGF also promoted PBI extrusion with high frequency. In experiments conducted in the presence of dbcAMP, FF-MAS was unable to promote an increase in germinal vesicle breakdown (GVBD) rate, whereas FSH and EGF generated a response similar to the Hx groups. Neither FSH, EGF nor FF-MAS caused any change in the meiotic status of CEO when meiotic arrest at the germinal vesicle (GV) stage was maintained by cilostamide. In the presence of Hx, naked oocytes (NkO) co-cultured with their cumulus cells were able to respond to the GVBD-inducing effect of FSH and EGF by resuming meiosis at high rate. CONCLUSIONS: Collectively, these results indicate that: (i) a signal triggered in cumulus cells by either FSH or EGF, but not necessarily coincident with FF-MAS, may contribute to meiotic maturation, supporting GVBD and extrusion of PBI; (ii) the transmission of this signal can occur in a paracrine fashion, at least with reference to the breakdown of the GV. It also appears that concomitant regulation of intra-oocyte cAMP degradation is a prerequisite for meiosis resumption.

Key words: cumulus cells/FSH/meiosis/oocyte development


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Biol. Reprod.Home page
C. X. Yeo, R. B. Gilchrist, and M. Lane
Disruption of Bidirectional Oocyte-Cumulus Paracrine Signaling During In Vitro Maturation Reduces Subsequent Mouse Oocyte Developmental Competence
Biol Reprod, May 1, 2009; 80(5): 1072 - 1080.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
G. Ning, H. Ouyang, S. Wang, X. Chen, B. Xu, J. Yang, H. Zhang, M. Zhang, and G. Xia
3',5'-Cyclic Adenosine Monophosphate Response Element Binding Protein Up-Regulated Cytochrome P450 Lanosterol 14{alpha}-Demethylase Expression Involved in Follicle-Stimulating Hormone-Induced Mouse Oocyte Maturation
Mol. Endocrinol., July 1, 2008; 22(7): 1682 - 1694.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
F. H Thomas, R. S Ismail, J.-Y. Jiang, and B. C Vanderhyden
Kit Ligand 2 Promotes Murine Oocyte Growth In Vitro
Biol Reprod, January 1, 2008; 78(1): 167 - 175.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Cukurcam, I. Betzendahl, G. Michel, E. Vogt, C. Hegele-Hartung, B. Lindenthal, and U. Eichenlaub-Ritter
Influence of follicular fluid meiosis-activating sterol on aneuploidy rate and precocious chromatid segregation in aged mouse oocytes
Hum. Reprod., March 1, 2007; 22(3): 815 - 828.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. Rossi, G. Macchiarelli, M.G. Palmerini, R. Canipari, and S. Cecconi
Meiotic spindle configuration is differentially influenced by FSH and epidermal growth factor during in vitro maturation of mouse oocytes
Hum. Reprod., July 1, 2006; 21(7): 1765 - 1770.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
L. M Mehlmann
Stops and starts in mammalian oocytes: recent advances in understanding the regulation of meiotic arrest and oocyte maturation
Reproduction, December 1, 2005; 130(6): 791 - 799.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
D Nogueira, R Cortvrindt, B Everaerdt, and J Smitz
Effects of long-term in vitro exposure to phosphodiesterase type-3 inhibitors on follicle and oocyte development
Reproduction, August 1, 2005; 130(2): 177 - 186.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.